| Literature DB >> 27507958 |
Xing-Jie Chen1, Lu-Lu Liu2, Ji-Fang Cui3, Ya Wang4, An-Tao Chen5, Feng-Hua Li5, Wei-Hong Wang5, Han-Feng Zheng6, Ming-Yuan Gan7, Chun-Qiu Li7, David H K Shum8, Raymond C K Chan4.
Abstract
Mental time travel refers to the ability to recall past events and to imagine possible future events. Schizophrenia (SCZ) patients have problems in remembering specific personal experiences in the past and imagining what will happen in the future. This study aimed to examine episodic past and future thinking in SCZ spectrum disorders including SCZ patients and individuals with schizotypal personality disorder (SPD) proneness who are at risk for developing SCZ. Thirty-two SCZ patients, 30 SPD proneness individuals, and 33 healthy controls participated in the study. The Sentence Completion for Events from the Past Test (SCEPT) and the Sentence Completion for Events in the Future Test were used to measure past and future thinking abilities. Results showed that SCZ patients showed significantly reduced specificity in recalling past and imagining future events, they generated less proportion of specific and extended events compared to healthy controls. SPD proneness individuals only generated less extended events compared to healthy controls. The reduced specificity was mainly manifested in imagining future events. Both SCZ patients and SPD proneness individuals generated less positive events than controls. These results suggest that mental time travel impairments in SCZ spectrum disorders and have implications for understanding their cognitive and emotional deficits.Entities:
Keywords: episodic future thinking; mental time travel; past; schizophrenia; schizophrenia spectrum
Year: 2016 PMID: 27507958 PMCID: PMC4960265 DOI: 10.3389/fpsyg.2016.01121
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Demographic information of participants.
| Control ( | Schizophrenia ( | SPD proneness ( | ||||||
|---|---|---|---|---|---|---|---|---|
| Mean | Mean | Mean | ||||||
| Male: female | 20: 13 | 19: 13 | 8: 22 | 9.13 | 0.010 | |||
| Age | 28.09 | 9.39 | 34.75 | 9.23 | 19.96 | 1.75 | 26.49 | <0.001 |
| Education | 13.12 | 2.64 | 12.19 | 3.01 | 13.58 | 1.19 | 2.67 | 0.075 |
| IQ | 119.94 | 15.68 | 106.66 | 12.27 | 124.23 | 10.71 | 15.30 | <0.001 |
| SPQ score | 22.87 | 8.41 | ∖ | ∖ | 46.33 | 5.44 | 164.63 | <0.001 |
| Duration of illness (years) | 7.66 | 4.89 | ||||||
| Medication (chlopromazine equivalence mg/day) | 331.29 | 212.63 | ||||||
| PANSS | ||||||||
| Positive symptoms | 11.16 | 3.71 | ||||||
| Negative symptoms | 12.61 | 4.09 | ||||||
| General psychopathology | 23.29 | 6.81 | ||||||
| Total score | 47.06 | 12.81 | ||||||
| AIMS | 1.00 | 1.78 | ||||||
| BARS | 0.90 | 1.64 | ||||||
Mean (SD) proportions of the different response categories across task type in participants.
| Control | Schizophrenia | SPD proneness | Group | Time orientation | Interaction | ||||
|---|---|---|---|---|---|---|---|---|---|
| SCEPT | SCEFT | SCEPT | SCEFT | SCEPT | SCEFT | ||||
| Specific events | 0.340 (0.170) | 0.268 (0.134) | 0.307 (0.140) | 0.171 (0.122) | 0.352 (0.173) | 0.200 (0.144) | 0.017 | ns | 0.03 |
| Extended events | 0.298 (0.153) | 0.240 (0.149) | 0.148 (0.124) | 0.125 (0.128) | 0.130 (0.116) | 0.164 (0.150) | <0.001 | ns | ns |
| Categoric events | 0.130 (0.094) | 0.278 (0.114) | 0.190 (0.112) | 0.253 (0.122) | 0.239 (0.142) | 0.476 (0.192) | <0.001 | ns | 0.04 |
| Semantic associates | 0.242 (0.128) | 0.209 (0.119) | 0.338 (0.146) | 0.418 (0.168) | 0.276 (0.203) | 0.158 (0.155) | 0.004 | ns | <0.001 |
| Positive | 0.300 (0.163) | 0.471 (0.165) | 0.210 (0.129) | 0.367 (0.190) | 0.209 (0.153) | 0.336 (0.174) | 0.001 | ns | ns |
| Neutral | 0.499 (0.182) | 0.499 (0.158) | 0.585 (0.165) | 0.548 (0.185) | 0.582 (0.217) | 0.627 (0.169) | 0.004 | ns | ns |
| Negative | 0.201 (0.155) | 0.030 (0.054) | 0.188 (0.150) | 0.051 (0.138) | 0.206 (0.149) | 0.033 (0.077) | ns | ns | ns |